This study is testing a new drug called ADCE-T02 for people with advanced solid tumors. Tumors are abnormal growths of cells, and "advanced" means they have spread or can't be removed by surgery. The study is in phase 1, which means it's checking how safe the drug is, how well people can tolerate it (handle any side effects), and the best dose to use. The drug is also known as a tissue factor targeted antibody-drug conjugate. This means it's designed to find and attack cancer cells by connecting an antibody to a drug.
- This study is for people who have had at least one treatment before and still have growing tumors.
- Participants need to go through tests and might have to use contraception during and after the study.
- People with certain health problems or past treatments may not be able to join.
It is important to talk to your doctor to see if this study is right for you and to understand any risks or benefits. Your participation could help find new cancer treatments.
How understandable was the trial content above?
Hard to understand
Easy to understand